Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (321-330 of 607) with videos related to

Pageof 61
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 27, 2021
Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical PracticeDinesh Khanna, Alain Lescoat, David Roofeh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Annals of the Rheumatic Diseases|June 2, 2018
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosisChristopher P Denton, Voon H Ong, Shiwen Xu, et al.
Cells|July 14, 2023
Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma SkinMarvin L Frommer, Benjamin J Langridge, Laura Awad, et al.
Psychology, Health & Medicine|April 15, 2011
The psychological impact of facial changes in sclerodermaKavit Amin, A Clarke, B Sivakumar, et al.
The Journal of Investigative Dermatology|June 10, 2011
Loss of PTEN expression by dermal fibroblasts causes skin fibrosisSunil K Parapuram, Xu Shi-wen, Christopher Elliott, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2015
Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic SclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Rheumatology (Oxford, England)|February 8, 2018
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosisOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Scientific Reports|February 25, 2017
Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic SclerosisJohannes P Schwaiger, Christopher D Loder, David Dobarro, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2010
An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptorRachel K Hoyles, Emma C Derrett-Smith, Korsa Khan, et al.
Pageof 61

Showing results (321-330 of 607) with videos related to

Sort By:
Pageof 61
Arthritis & Rheumatology (Hoboken, N.J.)|July 27, 2021
Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical PracticeDinesh Khanna, Alain Lescoat, David Roofeh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 29, 2014
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Annals of the Rheumatic Diseases|June 2, 2018
Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosisChristopher P Denton, Voon H Ong, Shiwen Xu, et al.
Cells|July 14, 2023
Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma SkinMarvin L Frommer, Benjamin J Langridge, Laura Awad, et al.
Psychology, Health & Medicine|April 15, 2011
The psychological impact of facial changes in sclerodermaKavit Amin, A Clarke, B Sivakumar, et al.
The Journal of Investigative Dermatology|June 10, 2011
Loss of PTEN expression by dermal fibroblasts causes skin fibrosisSunil K Parapuram, Xu Shi-wen, Christopher Elliott, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 12, 2015
Derivation and External Validation of a Prediction Rule for Five-Year Mortality in Patients With Early Diffuse Cutaneous Systemic SclerosisRobyn T Domsic, Svetlana I Nihtyanova, Stephen R Wisniewski, et al.
Rheumatology (Oxford, England)|February 8, 2018
Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosisOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Scientific Reports|February 25, 2017
Optical coherence tomography evaluation of pulmonary arterial vasculopathy in Systemic SclerosisJohannes P Schwaiger, Christopher D Loder, David Dobarro, et al.
American Journal of Respiratory and Critical Care Medicine|August 17, 2010
An essential role for resident fibroblasts in experimental lung fibrosis is defined by lineage-specific deletion of high-affinity type II transforming growth factor β receptorRachel K Hoyles, Emma C Derrett-Smith, Korsa Khan, et al.
Pageof 61